Top compounds associated with response to CYP26C1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	SN-38	GDSC1000	pan-cancer	AAC	-0.071	0.03
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.079	0.03
mRNA	MP470	GDSC1000	pan-cancer	AAC	0.073	0.03
mRNA	NSC632839	CTRPv2	pan-cancer	AAC	-0.07	0.04
mRNA	Obatoclax Mesylate	GDSC1000	pan-cancer	AAC	-0.07	0.04
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.067	0.04
mRNA	YK 4-279	CTRPv2	pan-cancer	AAC	0.066	0.04
mRNA	NSC-87877	GDSC1000	pan-cancer	AAC	-0.071	0.04
mRNA	lenalidomide	GDSC1000	pan-cancer	AAC	0.072	0.04
mRNA	HBX-41108	CTRPv2	pan-cancer	AAC	-0.085	0.04

Download CSV